17-82905981-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005993.5(TBCD):​c.1850T>C​(p.Met617Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,607,640 control chromosomes in the GnomAD database, including 157,642 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M617R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.48 ( 18827 hom., cov: 34)
Exomes 𝑓: 0.43 ( 138815 hom. )

Consequence

TBCD
NM_005993.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.106

Publications

50 publications found
Variant links:
Genes affected
TBCD (HGNC:11581): (tubulin folding cofactor D) Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
TBCD Gene-Disease associations (from GenCC):
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.391527E-6).
BP6
Variant 17-82905981-T-C is Benign according to our data. Variant chr17-82905981-T-C is described in ClinVar as Benign. ClinVar VariationId is 1167401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.65 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBCDNM_005993.5 linkc.1850T>C p.Met617Thr missense_variant Exon 20 of 39 ENST00000355528.9 NP_005984.3 Q9BTW9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBCDENST00000355528.9 linkc.1850T>C p.Met617Thr missense_variant Exon 20 of 39 1 NM_005993.5 ENSP00000347719.4 Q9BTW9-1

Frequencies

GnomAD3 genomes
AF:
0.485
AC:
73650
AN:
151994
Hom.:
18812
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.656
Gnomad AMI
AF:
0.248
Gnomad AMR
AF:
0.414
Gnomad ASJ
AF:
0.488
Gnomad EAS
AF:
0.287
Gnomad SAS
AF:
0.538
Gnomad FIN
AF:
0.408
Gnomad MID
AF:
0.538
Gnomad NFE
AF:
0.422
Gnomad OTH
AF:
0.468
GnomAD2 exomes
AF:
0.438
AC:
107922
AN:
246480
AF XY:
0.443
show subpopulations
Gnomad AFR exome
AF:
0.662
Gnomad AMR exome
AF:
0.373
Gnomad ASJ exome
AF:
0.483
Gnomad EAS exome
AF:
0.270
Gnomad FIN exome
AF:
0.414
Gnomad NFE exome
AF:
0.427
Gnomad OTH exome
AF:
0.446
GnomAD4 exome
AF:
0.433
AC:
629770
AN:
1455528
Hom.:
138815
Cov.:
44
AF XY:
0.435
AC XY:
315065
AN XY:
723978
show subpopulations
African (AFR)
AF:
0.667
AC:
22224
AN:
33300
American (AMR)
AF:
0.383
AC:
17029
AN:
44446
Ashkenazi Jewish (ASJ)
AF:
0.484
AC:
12638
AN:
26110
East Asian (EAS)
AF:
0.258
AC:
10215
AN:
39644
South Asian (SAS)
AF:
0.536
AC:
46075
AN:
85890
European-Finnish (FIN)
AF:
0.416
AC:
22097
AN:
53152
Middle Eastern (MID)
AF:
0.538
AC:
3098
AN:
5760
European-Non Finnish (NFE)
AF:
0.424
AC:
469439
AN:
1107036
Other (OTH)
AF:
0.448
AC:
26955
AN:
60190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
17790
35580
53371
71161
88951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14460
28920
43380
57840
72300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.485
AC:
73705
AN:
152112
Hom.:
18827
Cov.:
34
AF XY:
0.482
AC XY:
35822
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.656
AC:
27221
AN:
41488
American (AMR)
AF:
0.414
AC:
6334
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.488
AC:
1694
AN:
3468
East Asian (EAS)
AF:
0.287
AC:
1486
AN:
5172
South Asian (SAS)
AF:
0.537
AC:
2593
AN:
4828
European-Finnish (FIN)
AF:
0.408
AC:
4317
AN:
10574
Middle Eastern (MID)
AF:
0.527
AC:
154
AN:
292
European-Non Finnish (NFE)
AF:
0.422
AC:
28699
AN:
67970
Other (OTH)
AF:
0.464
AC:
981
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1933
3867
5800
7734
9667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
642
1284
1926
2568
3210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.444
Hom.:
52735
Bravo
AF:
0.491
TwinsUK
AF:
0.426
AC:
1579
ALSPAC
AF:
0.423
AC:
1630
ESP6500AA
AF:
0.674
AC:
2857
ESP6500EA
AF:
0.431
AC:
3645
ExAC
AF:
0.447
AC:
54064
Asia WGS
AF:
0.448
AC:
1555
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 06, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
0.13
DANN
Benign
0.21
DEOGEN2
Benign
0.014
T;.;.;.;T;T;.;T;.;.;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0028
N
LIST_S2
Benign
0.023
T;T;T;T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0000044
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-2.3
N;.;.;.;.;.;.;.;.;.;.
PhyloP100
0.11
PrimateAI
Benign
0.35
T
PROVEAN
Benign
2.8
N;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.094
Sift
Benign
1.0
T;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
1.0
T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
B;.;.;.;.;.;.;.;.;.;.
Vest4
0.10
MPC
0.33
ClinPred
0.0024
T
GERP RS
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.014
gMVP
0.15
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2292971; hg19: chr17-80863857; COSMIC: COSV62797771; COSMIC: COSV62797771; API